Commonwealth Equity Services’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Commonwealth Equity Services’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-162	Closed	-$80K	–	2277
2015 Q4	$80K	Hold	162	–	–	﹤0.01%	2058
2015 Q3	$190K	Sell	162 -10	-6%	-$15.3K	﹤0.01%	1852
2015 Q2	$303K	Sell	172 -9	-5%	-$14K	﹤0.01%	1631
2015 Q1	$212K	Hold	181	–	–	﹤0.01%	1876
2014 Q4	$181K	Buy	181 +10	+6%	+$10K	﹤0.01%	1869
2014 Q3	$230K	Sell	171 -1	-0.6%	-$1.43K	﹤0.01%	1737
2014 Q2	$292K	Hold	172	–	–	﹤0.01%	1567
2014 Q1	$389K	Buy	172 +1	+0.6%	+$2.56K	0.01%	1320
2013 Q4	$353K	Buy	+171	New	+$369K	0.01%	1339

Other funds holding VYNT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QGM

Quality Growth Management Rancho Santa Fe, California $88.9M AUM

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diker Management New York $130M AUM 97.77% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Commonwealth Equity Services's VYNT Position: Q1 2016 in Review

Commonwealth Equity Services sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2016, closing a stake of 162 shares — an estimated $80K sold.

Commonwealth Equity Services first reported a position in VYNT in Q4 2013 and held it in 9 quarters. The position peaked at $389K in Q1 2014. 29 funds tracked by Wall St. Rank hold VYNT as of Q1 2016.

Commonwealth Equity Services reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Commonwealth Equity Services sold 162 Vyant Bio, Inc. Common Stock shares in Q1 2016, an estimated $80K.
Commonwealth Equity Services first reported a position in Vyant Bio, Inc. Common Stock in Q4 2013 and held it in 9 quarters.
Commonwealth Equity Services's Vyant Bio, Inc. Common Stock position peaked at $389K in Q1 2014.
29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2016.

Based on Commonwealth Equity Services's 13F filing for Q1 2016, filed 27 Apr 2016.